title: Alzheimer disease: the landscape of ageing--insights from AD imaging markers.
abstract: The knowledge of imaging and fluid biomarkers gained from longitudinal observational studies of Alzheimer disease has recently been translated to a cross-sectional study of randomly selected, cognitively unimpaired elderly individuals. This is the first time that a two-feature biomarker classification system has been applied to a population-based cohort.
authors.affiliation: Department of Nuclear Medicine and Centre for PET, Austin Health, Melbourne, 145 Studley Road, Heidelberg, Vic 3084, Australia.
authors.forename: Victor L
authors.initials: VL
authors.lastname: Villemagne
authors.affiliation: The Florey Institute for Neuroscience and Mental Health, University of Melbourne, Genetics Lane, Royal Parade, Melbourne, Vic 3010, Australia.
authors.forename: Colin L
authors.initials: CL
authors.lastname: Masters
mesh_terms: D000375:Aging / Q000378:metabolism* / Q000473:pathology*; D000544:Alzheimer Disease / Q000175:diagnosis / Q000453:epidemiology / Q000378:metabolism* / Q000473:pathology*; D016229:Amyloid beta-Peptides / Q000378:metabolism; D015415:Biomarkers / Q000378:metabolism; D006801:Humans; D009410:Nerve Degeneration / Q000378:metabolism / Q000473:pathology; D059906:Neuroimaging
chemical_list: D016229:Amyloid beta-Peptides; D015415:Biomarkers